1
|
Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment.
|
J Biol Chem
|
2004
|
1.86
|
2
|
Palm mutants in DNA polymerases alpha and eta alter DNA replication fidelity and translesion activity.
|
Mol Cell Biol
|
2004
|
1.85
|
3
|
Conserved protein kinases encoded by herpesviruses and cellular protein kinase cdc2 target the same phosphorylation site in eukaryotic elongation factor 1delta.
|
J Virol
|
2003
|
1.72
|
4
|
Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation.
|
Clin Infect Dis
|
2008
|
1.54
|
5
|
Identification of proteins phosphorylated directly by the Us3 protein kinase encoded by herpes simplex virus 1.
|
J Virol
|
2005
|
1.50
|
6
|
Reactivation of lytic replication from B cells latently infected with Epstein-Barr virus occurs with high S-phase cyclin-dependent kinase activity while inhibiting cellular DNA replication.
|
J Virol
|
2003
|
1.39
|
7
|
Measuring Epstein-Barr virus (EBV) load: the significance and application for each EBV-associated disease.
|
Rev Med Virol
|
2008
|
1.34
|
8
|
Herpes simplex virus 1-encoded protein kinase UL13 phosphorylates viral Us3 protein kinase and regulates nuclear localization of viral envelopment factors UL34 and UL31.
|
J Virol
|
2006
|
1.33
|
9
|
Identification of a physiological phosphorylation site of the herpes simplex virus 1-encoded protein kinase Us3 which regulates its optimal catalytic activity in vitro and influences its function in infected cells.
|
J Virol
|
2008
|
1.32
|
10
|
Rapid diagnosis of human herpesvirus 6 infection by a novel DNA amplification method, loop-mediated isothermal amplification.
|
J Clin Microbiol
|
2004
|
1.24
|
11
|
Olfactory transmission of neurotropic viruses.
|
J Neurovirol
|
2005
|
1.23
|
12
|
Identification of protein kinases responsible for phosphorylation of Epstein-Barr virus nuclear antigen leader protein at serine-35, which regulates its coactivator function.
|
J Gen Virol
|
2003
|
1.21
|
13
|
Epstein-Barr virus protein kinase BGLF4 is a virion tegument protein that dissociates from virions in a phosphorylation-dependent process and phosphorylates the viral immediate-early protein BZLF1.
|
J Virol
|
2006
|
1.20
|
14
|
Herpes simplex virus type 1 UL51 protein is involved in maturation and egress of virus particles.
|
J Virol
|
2005
|
1.19
|
15
|
Rapid diagnosis of herpes simplex virus infection by a loop-mediated isothermal amplification method.
|
J Clin Microbiol
|
2005
|
1.17
|
16
|
Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.
|
J Virol
|
2004
|
1.15
|
17
|
Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2.
|
J Med Virol
|
2002
|
1.15
|
18
|
The role of protein kinase activity expressed by the UL13 gene of herpes simplex virus 1: the activity is not essential for optimal expression of UL41 and ICP0.
|
Virology
|
2005
|
1.13
|
19
|
Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay.
|
J Clin Microbiol
|
2007
|
1.08
|
20
|
Formation of aggresome-like structures in herpes simplex virus type 2-infected cells and a potential role in virus assembly.
|
Exp Cell Res
|
2004
|
1.06
|
21
|
Identification and characterization of the UL56 gene product of herpes simplex virus type 2.
|
J Virol
|
2002
|
1.06
|
22
|
Herpes simplex virus type 2 UL56 interacts with the ubiquitin ligase Nedd4 and increases its ubiquitination.
|
J Virol
|
2008
|
1.06
|
23
|
Construction of recombinant herpes simplex virus type I expressing green fluorescent protein without loss of any viral genes.
|
Microbes Infect
|
2004
|
1.05
|
24
|
Herpes simplex virus type 2 membrane protein UL56 associates with the kinesin motor protein KIF1A.
|
J Gen Virol
|
2005
|
1.05
|
25
|
Subcellular localization of herpes simplex virus type 1 UL51 protein and role of palmitoylation in Golgi apparatus targeting.
|
J Virol
|
2003
|
1.05
|
26
|
Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases.
|
J Infect Dis
|
2009
|
1.04
|
27
|
Differences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2.
|
J Virol
|
2009
|
1.03
|
28
|
Degradation of phosphorylated p53 by viral protein-ECS E3 ligase complex.
|
PLoS Pathog
|
2009
|
1.03
|
29
|
Detection of human herpesvirus 7 DNA by loop-mediated isothermal amplification.
|
J Clin Microbiol
|
2004
|
1.03
|
30
|
One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
|
J Virol Methods
|
2007
|
1.01
|
31
|
Human herpesvirus 6 viremia in bone marrow transplant recipients: clinical features and risk factors.
|
J Infect Dis
|
2002
|
1.01
|
32
|
Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus.
|
Microbes Infect
|
2006
|
1.01
|
33
|
The vomeronasal chemosensory system as a route of neuroinvasion by herpes simplex virus.
|
Virology
|
2005
|
0.98
|
34
|
Mitochondria and viruses.
|
Mitochondrion
|
2010
|
0.98
|
35
|
Mast cells play a key role in host defense against herpes simplex virus infection through TNF-α and IL-6 production.
|
J Invest Dermatol
|
2013
|
0.98
|
36
|
Monitoring of active HHV-6 infection in bone marrow transplant recipients by real time PCR; comparison to detection of viral DNA in plasma by qualitative PCR.
|
Microbiol Immunol
|
2002
|
0.98
|
37
|
Pilot study of oncolytic viral therapy using mutant herpes simplex virus (HF10) against recurrent metastatic breast cancer.
|
Ann Surg Oncol
|
2006
|
0.97
|
38
|
Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection.
|
J Gen Virol
|
2009
|
0.96
|
39
|
Herpes simplex virus 1 protein kinase Us3 and major tegument protein UL47 reciprocally regulate their subcellular localization in infected cells.
|
J Virol
|
2011
|
0.96
|
40
|
Monitoring herpesvirus DNA in three cases of acute retinal necrosis by real-time PCR.
|
J Clin Virol
|
2004
|
0.94
|
41
|
Olfactory receptor neurons prevent dissemination of neurovirulent influenza A virus into the brain by undergoing virus-induced apoptosis.
|
J Gen Virol
|
2002
|
0.94
|
42
|
Multiplex real-time PCR for the simultaneous detection of herpes simplex virus, human herpesvirus 6, and human herpesvirus 7.
|
Microbiol Immunol
|
2009
|
0.94
|
43
|
Application of flow cytometric in situ hybridization assay to Epstein-Barr virus-associated T/natural killer cell lymphoproliferative diseases.
|
Cancer Sci
|
2012
|
0.94
|
44
|
Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
|
J Med Virol
|
2006
|
0.94
|
45
|
Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
|
J Dermatol Sci
|
2008
|
0.93
|
46
|
Herpes simplex virus type 2 UL14 gene product has heat shock protein (HSP)-like functions.
|
J Cell Sci
|
2002
|
0.93
|
47
|
Intratumoral injection of herpes simplex virus HF10 in recurrent head and neck squamous cell carcinoma.
|
Acta Otolaryngol
|
2006
|
0.93
|
48
|
Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription.
|
Virology
|
2009
|
0.93
|
49
|
Herpes simplex virus type 2 US3 blocks apoptosis induced by sorbitol treatment.
|
Microbes Infect
|
2002
|
0.93
|
50
|
Identification and characterization of the UL7 gene product of herpes simplex virus type 2.
|
Virus Genes
|
2002
|
0.92
|
51
|
Epstein-Barr virus nuclear antigen leader protein induces expression of thymus- and activation-regulated chemokine in B cells.
|
J Virol
|
2004
|
0.92
|
52
|
Apoptosis induction after herpes simplex virus infection differs according to cell type in vivo.
|
Arch Virol
|
2010
|
0.91
|
53
|
Spatiotemporally different DNA repair systems participate in Epstein-Barr virus genome maturation.
|
J Virol
|
2011
|
0.91
|
54
|
US3 protein kinase of herpes simplex virus type 2 is required for the stability of the UL46-encoded tegument protein and its association with virus particles.
|
J Gen Virol
|
2005
|
0.91
|
55
|
Association of two membrane proteins encoded by herpes simplex virus type 2, UL11 and UL56.
|
Virus Genes
|
2006
|
0.90
|
56
|
Phosphorylation of cytokeratin 17 by herpes simplex virus type 2 US3 protein kinase.
|
Microbiol Immunol
|
2002
|
0.90
|
57
|
Protective role of Fas-FasL signaling in lethal infection with herpes simplex virus type 2 in mice.
|
J Virol
|
2009
|
0.90
|
58
|
Intraepithelial gammadelta T cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2.
|
J Virol
|
2004
|
0.90
|
59
|
Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease.
|
J Med Virol
|
2004
|
0.89
|
60
|
The UL14 tegument protein of herpes simplex virus type 1 is required for efficient nuclear transport of the alpha transinducing factor VP16 and viral capsids.
|
J Virol
|
2007
|
0.89
|
61
|
Rapid detection of varicella-zoster virus infection by a loop-mediated isothermal amplification method.
|
J Med Virol
|
2004
|
0.89
|
62
|
Herpes simplex virus type 2 tegument protein UL56 relocalizes ubiquitin ligase Nedd4 and has a role in transport and/or release of virions.
|
Virol J
|
2009
|
0.88
|
63
|
A regulatory role of interleukin 15 in wound healing and mucosal infection in mice.
|
J Leukoc Biol
|
2007
|
0.88
|
64
|
Latent infection of human herpesvirus 6 in astrocytoma cell line and alteration of cytokine synthesis.
|
J Med Virol
|
2002
|
0.87
|
65
|
Herpes simplex virus protein UL11 but not UL51 is associated with lipid rafts.
|
Virus Genes
|
2007
|
0.87
|
66
|
Oncolytic viral therapy with a combination of HF10, a herpes simplex virus type 1 variant and granulocyte-macrophage colony-stimulating factor for murine ovarian cancer.
|
Int J Cancer
|
2013
|
0.87
|
67
|
Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.
|
Int J Cancer
|
2011
|
0.86
|
68
|
Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.
|
Cancer Sci
|
2011
|
0.86
|
69
|
Herpes simplex virus requires poly(ADP-ribose) polymerase activity for efficient replication and induces extracellular signal-related kinase-dependent phosphorylation and ICP0-dependent nuclear localization of tankyrase 1.
|
J Virol
|
2011
|
0.86
|
70
|
Virus-induced neuronal apoptosis as pathological and protective responses of the host.
|
Rev Med Virol
|
2004
|
0.86
|
71
|
Microarray analysis of transcriptional responses to infection by herpes simplex virus types 1 and 2 and their US3-deficient mutants.
|
Microbes Infect
|
2008
|
0.85
|
72
|
Herpes simplex virus US3 protein kinase regulates virus-induced apoptosis in olfactory and vomeronasal chemosensory neurons in vivo.
|
Microbes Infect
|
2006
|
0.85
|
73
|
Iba1-expressing microglia respond to herpes simplex virus infection in the mouse trigeminal ganglion.
|
Brain Res Mol Brain Res
|
2003
|
0.85
|
74
|
Herpes simplex virus and varicella-zoster virus: why do these human alphaherpesviruses behave so differently from one another?
|
Rev Med Virol
|
2005
|
0.85
|
75
|
Successful protection by amantadine hydrochloride against lethal encephalitis caused by a highly neurovirulent recombinant influenza A virus in mice.
|
Virology
|
2002
|
0.84
|
76
|
Herpes simplex virus UL14 protein blocks apoptosis.
|
Microbiol Immunol
|
2003
|
0.84
|
77
|
Serological examination of human herpesvirus 6 and 7 in patients with coronary artery disease.
|
J Med Virol
|
2002
|
0.84
|
78
|
Detection of human cytomegalovirus DNA in perilymph of patients with sensorineural hearing loss using real-time PCR.
|
J Med Virol
|
2003
|
0.83
|
79
|
Herpes simplex virus UL56 interacts with and regulates the Nedd4-family ubiquitin ligase Itch.
|
Virol J
|
2010
|
0.83
|
80
|
Anti-apoptotic protein kinase of herpes simplex virus.
|
Trends Microbiol
|
2002
|
0.83
|
81
|
Overexpression of interleukin-15 prevents the development of murine retrovirus-induced acquired immunodeficiency syndrome.
|
FASEB J
|
2002
|
0.83
|
82
|
Multiplex real-time PCR assay for simultaneous quantification of BK polyomavirus, JC polyomavirus, and adenovirus DNA.
|
J Clin Microbiol
|
2010
|
0.82
|
83
|
Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model.
|
Gynecol Oncol
|
2003
|
0.82
|
84
|
Herpes simplex virus induces extensive modification and dynamic relocalisation of the nuclear mitotic apparatus (NuMA) protein in interphase cells.
|
J Cell Sci
|
2008
|
0.82
|
85
|
Non-engineered, naturally oncolytic herpes simplex virus HSV1 HF-10: applications for cancer gene therapy.
|
Curr Gene Ther
|
2008
|
0.82
|
86
|
Oncolytic viral therapy for breast cancer with herpes simplex virus type 1 mutant HF 10.
|
J Surg Oncol
|
2004
|
0.81
|
87
|
Variation of human herpesvirus 7 shedding in saliva.
|
J Infect Dis
|
2003
|
0.81
|
88
|
Accessory genes define the relationship between the herpes simplex virus and its host.
|
Microbes Infect
|
2006
|
0.81
|
89
|
Differential activation of the c-Jun N-terminal kinase/stress-activated protein kinase and p38 mitogen-activated protein kinase signal transduction pathways in the mouse brain upon infection with neurovirulent influenza A virus.
|
J Gen Virol
|
2003
|
0.81
|
90
|
Fatal adult case of severe lymphocytopenia associated with reactivation of human herpesvirus 6.
|
J Med Virol
|
2002
|
0.81
|
91
|
Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection.
|
J Infect Dis
|
2008
|
0.81
|
92
|
Enhanced antitumoral activity of oncolytic herpes simplex virus with gemcitabine using colorectal tumor models.
|
Int J Cancer
|
2012
|
0.81
|
93
|
Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex viruses.
|
Hepatogastroenterology
|
2003
|
0.81
|
94
|
Excretion of herpes simplex virus type 2 glycoprotein D into the culture medium.
|
J Gen Virol
|
2002
|
0.81
|
95
|
Detection of herpesvirus DNAs in perilymph obtained from patients with sensorineural hearing loss by real-time polymerase chain reaction.
|
Laryngoscope
|
2004
|
0.81
|
96
|
Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.
|
Cancer Lett
|
2009
|
0.80
|
97
|
Rapid detection of Epstein-Barr virus DNA by loop-mediated isothermal amplification method.
|
J Clin Virol
|
2006
|
0.80
|
98
|
Development of a human herpesvirus 6 species-specific immunoblotting assay.
|
J Clin Microbiol
|
2012
|
0.80
|
99
|
Replication-competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment.
|
J Gene Med
|
2007
|
0.80
|
100
|
Human herpesvirus 7-associated meningitis and optic neuritis in a patient after allogeneic stem cell transplantation.
|
J Med Virol
|
2003
|
0.80
|
101
|
Detection of cytomegalovirus DNA in preserved umbilical cords from patients with sensorineural hearing loss.
|
Eur Arch Otorhinolaryngol
|
2008
|
0.80
|
102
|
Immunologic and virologic analyses in pediatric liver transplant recipients with chronic high Epstein-Barr virus loads.
|
J Infect Dis
|
2010
|
0.80
|
103
|
Development of a monoclonal antibody against Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) that can detect EBNA-LP expressed in P3HR1 cells.
|
Microbiol Immunol
|
2005
|
0.79
|
104
|
Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?
|
Anticancer Agents Med Chem
|
2008
|
0.79
|
105
|
Latent infection of human herpesvirus 7 in CD4(+) T lymphocytes.
|
J Med Virol
|
2006
|
0.79
|
106
|
Evaluation of active human herpesvirus 6 infection by reverse transcription-PCR.
|
J Med Virol
|
2003
|
0.78
|
107
|
Phase I Dose-escalation Clinical Trial of HF10 Oncolytic Herpes Virus in 17 Japanese Patients with Advanced Cancer.
|
Hepatogastroenterology
|
2014
|
0.78
|
108
|
HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2.
|
Microbes Infect
|
2005
|
0.78
|
109
|
Diabetic mice show an aggravated course of herpes-simplex virus-induced facial nerve paralysis.
|
Otol Neurotol
|
2012
|
0.78
|
110
|
New estimation method for highly sensitive quantitation of human immunodeficiency virus type 1 DNA and its application.
|
J Virol Methods
|
2005
|
0.78
|
111
|
Generation and Characterization of UL21-Null Herpes Simplex Virus Type 1.
|
Front Microbiol
|
2012
|
0.78
|
112
|
The US3 protein kinase of herpes simplex virus attenuates the activation of the c-Jun N-terminal protein kinase signal transduction pathway in infected piriform cortex neurons of C57BL/6 mice.
|
Neurosci Lett
|
2003
|
0.78
|
113
|
Immunization with a highly attenuated replication-competent herpes simplex virus type 1 mutant, HF10, protects mice from genital disease caused by herpes simplex virus type 2.
|
Front Microbiol
|
2012
|
0.78
|
114
|
Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer.
|
Urology
|
2005
|
0.78
|
115
|
Treatment of solid sarcomas in immunocompetent mice with novel, oncolytic herpes simplex viruses.
|
Otolaryngol Head Neck Surg
|
2004
|
0.78
|
116
|
Intercellular trafficking of herpes simplex virus type 2 UL14 deletion mutant proteins.
|
Biochem Biophys Res Commun
|
2002
|
0.77
|
117
|
Herpes simplex virus type 1 UL14 tegument protein regulates intracellular compartmentalization of major tegument protein VP16.
|
Virol J
|
2011
|
0.77
|
118
|
Intercellular trafficking activity of herpes simplex virus US11 gene product in the mouse brain.
|
Brain Res Mol Brain Res
|
2005
|
0.77
|
119
|
Herpes simplex virus induces the marked up-regulation of the zinc finger transcriptional factor INSM1, which modulates the expression and localization of the immediate early protein ICP0.
|
Virol J
|
2011
|
0.77
|
120
|
Axonal injury in experimental herpes simplex encephalitis.
|
Brain Res
|
2005
|
0.77
|
121
|
PCR search for the herpes simplex virus type 1 genome in brain sections of patients with familial Alzheimer's disease.
|
J Clin Microbiol
|
2004
|
0.77
|
122
|
Oncotarget Strategies For Herpes Simplex Virus-1.
|
Curr Gene Ther
|
2016
|
0.76
|
123
|
Auditory and vestibular defects induced by experimental labyrinthitis following herpes simplex virus in mice.
|
Acta Otolaryngol
|
2011
|
0.76
|
124
|
Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.
|
Pharm Res
|
2007
|
0.75
|
125
|
The alpha4 residues of human DNA topoisomerase IIalpha function in enzymatic activity and anticancer drug sensitivity.
|
Nucleic Acids Res
|
2004
|
0.75
|
126
|
[Novel treatment with oncolytic herpes simplex virus, 'HF10' against breast cancer].
|
Nihon Rinsho
|
2004
|
0.75
|
127
|
HHV-6 and 7 DNA loads in lung tissues collected from patients with interstitial pneumonia.
|
J Med Virol
|
2005
|
0.75
|
128
|
Identification of Epstein-Barr virus-infected CD27+ memory B-cells in liver or stem cell transplant patients.
|
J Gen Virol
|
2011
|
0.75
|
129
|
Beneficial effect of GB virus C co-infection in Human Immunodeficiency Virus type 1-infected individuals.
|
Microbiol Immunol
|
2007
|
0.75
|
130
|
Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
|
J Virol Methods
|
2006
|
0.75
|
131
|
Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide.
|
Virus Genes
|
2006
|
0.75
|
132
|
Human herpesvirus 6 infection of human epidermal cell line: pathogenesis of skin manifestations.
|
J Med Virol
|
2003
|
0.75
|
133
|
[Replication mechanisms and molecular pathogenesis of herpes simplex viruses].
|
Tanpakushitsu Kakusan Koso
|
2009
|
0.75
|
134
|
[Varicella-zoster virus].
|
Nihon Rinsho
|
2003
|
0.75
|
135
|
Human herpesvirus 6 fulminant hepatic failure treated by living donor liver transplantation.
|
Pediatr Int
|
2004
|
0.75
|